{"formats":[{"name":"JSON","format":"json","url":"\/downloads\/2025\/code-json\/38.2-6606.json"},{"name":"Plain Text","format":"text","url":"\/downloads\/2025\/code-text\/38.2-6606.txt"},{"name":"XML","format":"xml","url":"\/downloads\/2025\/code-xml\/38.2-6606.xml"},{"name":"HTML","format":"html","url":"\/downloads\/2025\/code-html\/38.2-6606.html"}],"law_id":67978,"edition_id":1,"section_id":67978,"structure_id":15471,"section_number":"38.2-6606","catch_line":"State Innovation Waiver request","history":"2021, Sp. Sess. I, c. 480.","full_text":"A\n\nThe Commission shall apply to the appropriate federal agencies under 42 U.S.C. &#xA7; 18052 for a State Innovation Waiver for benefit years beginning January 1, 2023, and future years, (i) to establish a reinsurance program, in accordance with the provisions of this chapter; (ii) to maximize federal pass-through funding for the reinsurance program; (iii) to be able to use remaining funds for other uses as recommended by a work group established by the Secretary of Health and Human Resources; and (iv) to waive any applicable provisions of the Affordable Care Act. An application for a State Innovation Waiver or for federal funds shall clearly state that operation of the Program is contingent on approval of the waiver or funding request. The Commission shall include in the application a request for pass-through of federal funding in accordance with &#xA7; 1332(a)(3) of 42 U.S.C &#xA7; 18052 to allow the Commonwealth to obtain and use, for purposes of helping finance the Program, any federal funds that would, absent the waiver, be used to pay advance payment tax credits and cost-sharing reductions authorized under the federal act. The Commission is authorized to apply for, accept, administer, and expend gifts, grants, and donations, and any federal funds that become available for the implementation of the Program, including the use of amounts necessary to develop and submit the State Innovation Waiver and request for federal funding.B\n\nThe Commission shall submit the waiver application to the appropriate federal agencies by January 1, 2022. The Commission shall make a draft application available for public review and comment by October 1, 2021. The Commission may amend the waiver application as necessary to carry out the provisions of this chapter. The Commission shall promptly notify the Chairmen of the House Committees on Labor and Commerce and Appropriations and the Senate Committees on Commerce and Labor and Finance and Appropriations of any federal actions regarding the waiver request and of any amendment to the waiver application.","order_by":null,"text":{"0":{"id":246151,"text":"The Commission shall apply to the appropriate federal agencies under 42 U.S.C. &#xA7; 18052 for a State Innovation Waiver for benefit years beginning January 1, 2023, and future years, (i) to establish a reinsurance program, in accordance with the provisions of this chapter; (ii) to maximize federal pass-through funding for the reinsurance program; (iii) to be able to use remaining funds for other uses as recommended by a work group established by the Secretary of Health and Human Resources; and (iv) to waive any applicable provisions of the Affordable Care Act. An application for a State Innovation Waiver or for federal funds shall clearly state that operation of the Program is contingent on approval of the waiver or funding request. The Commission shall include in the application a request for pass-through of federal funding in accordance with &#xA7; 1332(a)(3) of 42 U.S.C &#xA7; 18052 to allow the Commonwealth to obtain and use, for purposes of helping finance the Program, any federal funds that would, absent the waiver, be used to pay advance payment tax credits and cost-sharing reductions authorized under the federal act. The Commission is authorized to apply for, accept, administer, and expend gifts, grants, and donations, and any federal funds that become available for the implementation of the Program, including the use of amounts necessary to develop and submit the State Innovation Waiver and request for federal funding.","type":"section","prefixes":["A"],"prefix":"A","entire_prefix":"A","prefix_anchor":"A","level":1,"next_prefix":"B"},"1":{"id":246152,"text":"The Commission shall submit the waiver application to the appropriate federal agencies by January 1, 2022. The Commission shall make a draft application available for public review and comment by October 1, 2021. The Commission may amend the waiver application as necessary to carry out the provisions of this chapter. The Commission shall promptly notify the Chairmen of the House Committees on Labor and Commerce and Appropriations and the Senate Committees on Commerce and Labor and Finance and Appropriations of any federal actions regarding the waiver request and of any amendment to the waiver application.","type":"section","prefixes":["B"],"prefix":"B","entire_prefix":"B","prefix_anchor":"B","level":1,"prior_prefix":"A"}},"ancestry":[{"id":15471,"edition_id":1,"name":"Commonwealth Health Reinsurance Program","identifier":"66","label":"chapter","depth":2,"order_by":1,"parent_id":12698,"metadata":{},"date_created":"2026-06-26 03:55:18","date_modified":"2026-06-26 03:55:18","permalink":{"id":218419,"object_type":"structure","relational_id":15471,"identifier":"66","token":"38.2\/66","url":"\/38.2\/66\/","edition_id":1,"permalink":0,"preferred":1}},{"id":12698,"edition_id":1,"name":"Insurance","identifier":"38.2","label":"title","depth":1,"order_by":1,"parent_id":null,"metadata":{},"date_created":"2026-06-26 03:43:49","date_modified":"2026-06-26 03:43:49","permalink":{"id":210661,"object_type":"structure","relational_id":12698,"identifier":"38.2","token":"38.2","url":"\/38.2\/","edition_id":1,"permalink":0,"preferred":1}}],"structure_contents":[{"id":76403,"structure_id":15471,"section_number":"38.2-6600","catch_line":"Definitions","url":"\/38.2-6600\/","token":"38.2\/66\/38.2-6600","metadata":false},{"id":58939,"structure_id":15471,"section_number":"38.2-6601","catch_line":"Commission powers and duties; rules; report","url":"\/38.2-6601\/","token":"38.2\/66\/38.2-6601","metadata":false},{"id":62335,"structure_id":15471,"section_number":"38.2-6602","catch_line":"Commonwealth Health Reinsurance Program; established","url":"\/38.2-6602\/","token":"38.2\/66\/38.2-6602","metadata":false},{"id":87443,"structure_id":15471,"section_number":"38.2-6603","catch_line":"Accounting; reports","url":"\/38.2-6603\/","token":"38.2\/66\/38.2-6603","metadata":false},{"id":87186,"structure_id":15471,"section_number":"38.2-6604","catch_line":"Commonwealth Health Reinsurance Program Special Fund","url":"\/38.2-6604\/","token":"38.2\/66\/38.2-6604","metadata":false},{"id":87098,"structure_id":15471,"section_number":"38.2-6605","catch_line":"Confidentiality of data","url":"\/38.2-6605\/","token":"38.2\/66\/38.2-6605","metadata":false},{"id":67978,"structure_id":15471,"section_number":"38.2-6606","catch_line":"State Innovation Waiver request","url":"\/38.2-6606\/","token":"38.2\/66\/38.2-6606","metadata":false}],"previous_section":{"id":87098,"structure_id":15471,"section_number":"38.2-6605","catch_line":"Confidentiality of data","url":"\/38.2-6605\/","token":"38.2\/66\/38.2-6605","metadata":false},"metadata":false,"official_url":"https:\/\/law.lis.virginia.gov\/vacode\/38.2-6606\/","history_text":false,"references":[{"id":58939,"section_number":"38.2-6601","catch_line":"Commission powers and duties; rules; report","order_by":null,"url":"\/38.2-6601\/"},{"id":62335,"section_number":"38.2-6602","catch_line":"Commonwealth Health Reinsurance Program; established","order_by":null,"url":"\/38.2-6602\/"},{"id":87186,"section_number":"38.2-6604","catch_line":"Commonwealth Health Reinsurance Program Special Fund","order_by":null,"url":"\/38.2-6604\/"}],"refers_to":false,"permalink":{"id":218445,"object_type":"law","relational_id":67978,"identifier":"38.2-6606","token":"38.2\/66\/38.2-6606","url":"\/38.2-6606\/","edition_id":1,"permalink":0,"preferred":1},"url":"\/38.2-6606\/","token":"38.2\/66\/38.2-6606","dublin_core":{"Title":"State Innovation Waiver request","Type":"Text","Format":"text\/html","Identifier":"\u00a7 38.2-6606","Relation":"Code of Virginia"},"html":"\n\t\t\t\t\t\t<section id=\"A\"><p><span class=\"prefix-number\">A.<\/span> The <span class=\"dictionary\">Commission<\/span> shall apply to the appropriate federal agencies under 42 U.S.C. &#xA7; 18052 for a <span class=\"dictionary\">State Innovation Waiver<\/span> for <span class=\"dictionary\">benefit years<\/span> beginning January 1, 2023, and future years, (i) to establish a reinsurance <span class=\"dictionary\">program<\/span>, in accordance with the provisions of this chapter; (ii) to maximize federal pass-through funding for the reinsurance <span class=\"dictionary\">program<\/span>; (iii) to be able to use remaining <span class=\"dictionary\">funds<\/span> for other uses as recommended by a work group established by the Secretary of Health and Human Resources; and (iv) to <span class=\"dictionary\">waive<\/span> any applicable provisions of the <span class=\"dictionary\">Affordable Care Act<\/span>. An application for a <span class=\"dictionary\">State Innovation Waiver<\/span> or for federal <span class=\"dictionary\">funds<\/span> shall clearly state that operation of the <span class=\"dictionary\">Program<\/span> is contingent on approval of the waiver or funding request. The <span class=\"dictionary\">Commission<\/span> shall include in the application a request for pass-through of federal funding in accordance with &#xA7; 1332(a)(3) of 42 U.S.C &#xA7; 18052 to allow the Commonwealth to obtain and use, for purposes of helping finance the <span class=\"dictionary\">Program<\/span>, any federal <span class=\"dictionary\">funds<\/span> that would, absent the waiver, be used to pay advance payment tax credits and cost-sharing reductions authorized under the federal act. The <span class=\"dictionary\">Commission<\/span> is authorized to apply for, accept, administer, and expend gifts, grants, and donations, and any federal <span class=\"dictionary\">funds<\/span> that become available for the implementation of the <span class=\"dictionary\">Program<\/span>, including the use of amounts necessary to develop and submit the <span class=\"dictionary\">State Innovation Waiver<\/span> and request for federal funding. <a id=\"paragraph-246151\" class=\"section-permalink\" href=\"https:\/\/vacode.org\/38.2-6606\/#A\"><i class=\"fa fa-link\"><\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t<section id=\"B\"><p><span class=\"prefix-number\">B.<\/span> The <span class=\"dictionary\">Commission<\/span> shall submit the waiver application to the appropriate federal agencies by January 1, 2022. The <span class=\"dictionary\">Commission<\/span> shall make a draft application available for public review and comment by October 1, 2021. The <span class=\"dictionary\">Commission<\/span> may <span class=\"dictionary\">amend<\/span> the waiver application as necessary to carry out the provisions of this chapter. The <span class=\"dictionary\">Commission<\/span> shall promptly notify the Chairmen of the House Committees on Labor and Commerce and Appropriations and the Senate Committees on Commerce and Labor and Finance and Appropriations of any federal actions regarding the waiver request and of any amendment to the waiver application. <a id=\"paragraph-246152\" class=\"section-permalink\" href=\"https:\/\/vacode.org\/38.2-6606\/#B\"><i class=\"fa fa-link\"><\/i><\/a><\/p><\/section>","plain_text":"                                 CODE OF VIRGINIA\n\nSTATE INNOVATION WAIVER REQUEST (\u00a7 38.2-6606)\n\nA. The Commission shall apply to the appropriate federal agencies under 42\nU.S.C. &#xA7; 18052 for a State Innovation Waiver for benefit years beginning\nJanuary 1, 2023, and future years, (i) to establish a reinsurance program, in\naccordance with the provisions of this chapter; (ii) to maximize federal\npass-through funding for the reinsurance program; (iii) to be able to use\nremaining funds for other uses as recommended by a work group established by the\nSecretary of Health and Human Resources; and (iv) to waive any applicable\nprovisions of the Affordable Care Act. An application for a State Innovation\nWaiver or for federal funds shall clearly state that operation of the Program is\ncontingent on approval of the waiver or funding request. The Commission shall\ninclude in the application a request for pass-through of federal funding in\naccordance with &#xA7; 1332(a)(3) of 42 U.S.C &#xA7; 18052 to allow the\nCommonwealth to obtain and use, for purposes of helping finance the Program, any\nfederal funds that would, absent the waiver, be used to pay advance payment tax\ncredits and cost-sharing reductions authorized under the federal act. The\nCommission is authorized to apply for, accept, administer, and expend gifts,\ngrants, and donations, and any federal funds that become available for the\nimplementation of the Program, including the use of amounts necessary to develop\nand submit the State Innovation Waiver and request for federal funding.\n\nB. The Commission shall submit the waiver application to the appropriate federal\nagencies by January 1, 2022. The Commission shall make a draft application\navailable for public review and comment by October 1, 2021. The Commission may\namend the waiver application as necessary to carry out the provisions of this\nchapter. The Commission shall promptly notify the Chairmen of the House\nCommittees on Labor and Commerce and Appropriations and the Senate Committees on\nCommerce and Labor and Finance and Appropriations of any federal actions\nregarding the waiver request and of any amendment to the waiver application.\n\nHISTORY: 2021, Sp. Sess. I, c. 480.","edition":{"id":1,"name":"2025","slug":"2025","date_created":"2026-06-21 22:39:22","date_modified":"2026-06-21 22:39:22","current":1,"order_by":1,"last_import":null}}